Biocatalytic Synthesis of Ruxolitinib Intermediate via Engineered Imine Reductase.

Xuewen Zhang, Yiming Yang, Na Zhang, Aiping Huang, Chengcheng Shi, Bifei Zhang, Xinkun Tuo, Peili Shen, Xuecheng Jiao

Journal: The Journal of organic chemistry 2024;89(16):11446-11454

PMID: 39113180

Abstract

An enzyme catalyzed strategy for the synthesis of a chiral hydrazine from 3-cyclopentyl-3-oxopropanenitrile and hydrazine hydrate is presented. An imine reductase (IRED) from was identified to catalyze the reaction between 3-cyclopentyl-3-oxopropanenitrile and hydrazine hydrate to produce trace amounts of ()-3-cyclopentyl-3-hydrazineylpropanenitrile . We employed a 2-fold approach to optimize the catalytic performance of this enzyme. First, a transition state analogue (TSA) model was constructed to illuminate the enzyme-substrate interactions. Subsequently, the Enzyme_design and Funclib methods were utilized to predict mutants for experimental evaluation. Through three rounds of site-directed mutagenesis, site saturation mutagenesis, and combinatorial mutagenesis, we obtained mutant M6 with a yield of 98% and an enantiomeric excess (ee) of 99%. This study presents an effective method for constructing a hydrazine derivative via IRED-catalyzed reductive amination of ketone and hydrazine. Furthermore, it provides a general approach for constructing suitable enzymes, starting from nonreactive enzymes and gradually enhancing their catalytic activity through active site modifications.

Address: Center of Biosynthesis Technology, Asymchem Life Science (Tianjin) Co, Ltd, Tianjin 300457, P.R. China.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.